AbbVie Free Cash Flow 2010-2024 | ABBV

AbbVie free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.

  • AbbVie annual free cash flow for 2024 was $17.832B, a 19.17% decline from 2023.
  • AbbVie annual free cash flow for 2023 was $22.062B, a 9.02% decline from 2022.
  • AbbVie annual free cash flow for 2022 was $24.248B, a 10.27% increase from 2021.

AbbVie Free Cash Flow 2010-2024 | ABBV

  • AbbVie annual free cash flow for 2024 was $17.832B, a 19.17% decline from 2023.
  • AbbVie annual free cash flow for 2023 was $22.062B, a 9.02% decline from 2022.
  • AbbVie annual free cash flow for 2022 was $24.248B, a 10.27% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B